1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in <i>Mycobacterium tuberculosis</i>.

Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"raw data tables for the chemoproteomics experiments can be found in tables s1"

Code Sharing
Evidence found in paper:

"The authors declare no competing financial interest."

Evidence found in paper:

"The project was funded through Global Health Grants (OPP1066878) received from the Bill and Melinda Gates Foundation and a matched grant from the Strategic Health Innovation Partnerships (SHIP) unit of the South African Medical Research Council (SAMRC) to K.C.; grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases AI130929 (to M.J.), AI153477 (to M.J. and S.G.), and P01AI095208 (to J.C.S.); and a grant from the Welch Foundation A-0015 (to J.C.S.). The University of Cape Town, SAMRC, and the South African Research Chairs Initiative of the Department of Science and Innovation, administered through the South African National Research Foundation, are gratefully acknowledged for their support (K.C.). The chemoproteomic work was performed through Global Health Grants (OPP1095631) received from the Bill and Melinda Gates Foundation to GSK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH and GSK."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025